6c3fd2dd__Trials_Monthly___October_2013__Description
[NCI Designation] NCT01556490 [Disease Site] Hepatocellular Carcinoma [Description] 
A Phase III Clinical Trial of Intra-Arterial TheraSphere in the Treatment of Patient with Unresectable Hepatocellular Carcinoma (HCC)
Seattle Cancer Care Alliance | Clinical Trials Monthly - October 2013
Description